| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 56.3% | 9/16 |
| Female | 43.8% | 7/16 |
| Indifferent | 0% | 0/16 |
| Unknown | 0% | 0/16 |
| General | ||
| Birth Length | 0% | 0/16 |
| 12.5% | 2/16 | |
| Birth Head circumference | 0% | 0/16 |
| 25% | 4/16 | |
| 12.5% | 2/16 | |
| 6.3% | 1/16 | |
| 62.5% | 10/16 | |
| 81.3% | 13/16 | |
| 56.3% | 9/16 | |
| 66.7% | 6/9 | |
| Neurology | ||
| 75% | 12/16 | |
| 68.8% | 11/16 | |
| 25% | 4/16 | |
| Facial abnormalities | ||
| 25% | 4/16 | |
| 50% | 8/16 | |
| 31.3% | 5/16 | |
| 43.8% | 7/16 | |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/16 |
| 37.5% | 6/16 | |
| Heart | ||
| Abnormality of the heart | 0% | 0/16 |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/16 |
| Gastrointestinal | ||
| Gastrointestinal | 0% | 0/16 |
| Urogenital | ||
| Urogenital | 0% | 0/16 |
| Skeleton | ||
| 50% | 8/16 | |
| Skin / Hair / Nails | ||
| 31.3% | 5/16 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/16 |
| Metabolic | 0% | 0/16 |
| Immune | 0% | 0/16 |
| Neoplasia | ||
| Neoplasia | 0% | 0/16 |
| Inheritance | ||
| 93.3% | 14/15 | |
CHD5